148results about How to "Suitable property" patented technology

Floorboards are shown, which consist of a core and a surface layer and are provided with decorative joint edges which are formed by removing the surface layer.

A method of fabricating hafnium oxide and / or zirconium oxide films is provided. The methods include providing a mixture of Hf and / or Zr alkoxide dissolved, emulsified or suspended in a liquid; vaporizing at least the alkoxide and depositing the vaporized component at a temperature of greater than 400° C. The resultant film is dense, microcrystalline and is capable of self-passivation when treated in a hydrogen plasma or forming gas anneal.

The capability of retaining a resistance value of a stored state and an erased state is improved in a resistance variation-type memory device. A memory layer 5 including a high-resistance layer 2 and an ion source layer 3 is provided between a lower electrode 1 and an upper electrode 4. The ion source layer 3 contains Al (aluminum) as an additive element together with an ion conductive material such as S (sulfur), Se (selenium), and Te (tellurium) (chalcogenide element) and a metal element to be ionized such as Zr (zirconium). Since Al is included in the ion source layer 3, the high-resistance layer which includes Al (Al oxide) is formed on an anode in erasing operation. Thus, a retaining property in a high-resistance state improves, and at the same time, an operating speed is improved.

In a power generation plant, for example a power station plant for the generation of electricity, a secondary machine (1a, 1b, 1c, 2) is connected downstream of an open-cycle gas turboset (100) for the utilization of the waste heat of the exhaust gases (107). The secondary machine is a machine working in a closed cycle with a gaseous process fluid, for example a closed-cycle gas turboset having a compressor (1a, 1b, 1c), a device for heating the compressed gas (6) which utilize the waste heat of the exhaust gas (107) of the primary gas turboset (100), a turbine (2) and at least one heat sink (13). In one embodiment, intercoolers (41, 42) are arranged during the compression process. A variable cycle charge of the secondary machine permits superior flexibility in the utilization of greatly varying supplies of waste heat available.

A regeneration member which, under nearly natural surroundings, is integrated into adjacent, surrounding, existent articular cartilage under good conditions and which is capable of early regenerating articular cartilage having an original thickness under continuous conditions, and a production method thereof are provided. Also, a regeneration method and a cultivation method, of articular cartilage, in vivo and in vitro are provided. Furthermore, an artificial articular cartilage obtained by these methods is provided. Using a member for articular cartilage regeneration having a hydroxyapatite porous element, having a number of pores distributed therein, substantially all of said pores being three-dimensionally communicated to each other through open portions, a porosity of from 50% to 90%, both inclusive, and an average pore diameter of from 100 μm to 600 μm, both inclusive, articular cartilage is regenerated and cultivated.

The present invention relates to pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of fenofibrate and the HMG CoA reductase inhibitor rosuvastatin or a pharmaceutically active salt thereof, which upon oral administration provides a relative AUC0-24 value (AUCfibric acid / AUCrosuvastatin) of between about 150 and about 12,000. The solid compositions are manufactured without any need of addition of water or aqueous medium and comprise at least 80% of the active substances fenofibrate and rosuvastatin in dissolved form, or, optionally, atorvastatin in micronized form, in order to ensure suitable bioavailability.

In all of an in-plane magnetic recording system and a perpendicular magnetic recording system, there is provided a crystallized glass for a disk substrate for information recording medium, etc., which has satisfactory surface properties capable of sufficiently adapting with a lamp loading system for high-density recording, has high strength such that it is able to withstand high-speed rotation and impact, has heat expansion properties and heat resistance in agreement with respective drive members, has a low melting temperature, has excellent productivity and is reduced in the elution amount of an alkali from the raw material, namely excellent in chemical durability. The crystallized glass of the invention is a crystallized glass containing an SiO2 component and an Li2O component; further containing at least one member selected from an SrO component and a BaO component in a total content of more than 3.5% and not more than 15% in terms of % by mass; and containing at least one member selected among lithium disilicate, lithium monosilicate, α-quartz, an α-quartz solid solution and a β-quartz solid solution as a main crystal phase on the oxide basis.

A fugitive pattern for making a shell mold for investment casting a metal or alloy comprises a substantially random interpolymer and a low molecular weight polymer in proportions to provide a fugitive pattern having a combination of properties suitable for use in making the shell molds.

Processable rubber compositions contain a vulcanized fluorocarbon elastomer dispersed in a thermoplastic matrix comprising a fully fluorinated polymer and a partially fluorinated polymer. The processing temperature is below the melting point of the fully fluorinated polymer. The compositions are made by combining a curative, uncured fluorocarbon elastomer, a fully fluorinated thermoplastic, and a partially fluorinated thermoplastic material, and heating the mixture at a temperature and for a time sufficient to effect vulcanization of the elastomeric material, while mechanical energy is applied to mix the mixture during the heating step. Shaped articles such as seals, gaskets, O-rings, and hoses may be readily formed from the rubber compositions according to conventional thermoplastic processes such as blow molding, injection molding, and extrusion.

The present invention relates to metal oxide coating materials that can be used as thin film thin film coatings on various substrate surfaces. The invention also concerns a method of making metal oxide material which are stable in aqueous phase and that can be deposited on a substrate by liquid phase deposition, such as spin-on deposition. The new materials can be patterned lithographically or non-lithographically and are applicable for building up various electronic and opto-electronic device structures, such as anti-reflection layers, high-k interlayer and gate oxide structures for ICs, etch stop layer, CMP stop layer, solar cells, OLEDs packaging, optical thin film filters, optical diffractive grating applications and hybrid thin film diffractive grating structures.

A process involves adding a peroxide masterbatch to a molten blend of a fluorocarbon elastomer and a thermoplastic material. The peroxide masterbatch contains greater than or equal to 5% weight percent organic peroxide, further contains a fluorocarbon elastomer, and typically also contains a crosslinker containing at least two sites of olefinic unsaturation. The fluorocarbon elastomer in the molten blend and in the peroxide masterbatch may be the same or different. After the peroxide masterbatch is added to the molten blend, the combination is mixed at a temperature and for a time sufficient to effect cure of the fluorocarbon elastomers. By using a masterbatch, a faster and more uniform dispersion of peroxide curative is possible due to pre-dispersion of peroxide in the elastomer phase, which leads to shaped articles having improved mechanical properties.

A cyclohexane derivative having the function of reducing a blood sugar level and having preferable properties required of medicines, such as long-lasting drug activity, metabolic stability, and safety; and a medicinal composition for use in the prevention or treatment of diseases attributable to hyperglycemia, such as diabetes, e.g., insulin dependent diabetes mellitus (type 1 diabetes) or noninsulin-dependent diabetes mellitus (type 2 diabetes), complications of diabetes, and obesity. The derivative is a compound represented by the formula (I):(wherein A is —O—, —CH2—, or —NH—; n is an integer selected between 0 and 1; R6 and R7 each independently is hydrogen or C1-6 alkyl; m is an integer selected among 1-3; Q is selected among the following formulae Q1 to Q5;Ar1 is optionally substituted arylene or optionally substituted heteroarylene, provided that the heteroarylene may be bonded to an aromatic carbocycle or aromatic heterocycle to form a fused ring; and Ar2 is optionally substituted aryl or optionally substituted heteroaryl), a prodrug of the compound, or a pharmaceutically acceptable salt of either. Also provided are a medicine, a medicinal composition, or the like each containing the compound.

Disclosed is a field-effect transistor characterized by using a compound represented by the formula (1) below as a semiconductor material.(In the formula (1), X1 and X2 independently represent a sulfur atom, a selenium atom or a tellurium atom; and R1 and R2 independently represent an unsubstituted or halogeno-substituted C1-C36 aliphatic hydrocarbon group.)

A flame-retardant resin composition comprising (A)(1) a resin component containing an aromatic polycarbonate resin and a styrene-containing resin or (2) a resin component containing a polyphenylene ether resin and a polystyrene, and (B) a flame retardant that is a phosphoric ester of the following formula (I), wherein each of R1, R2, R3 and R4 is independently an aryl group having 6 to 12 carbon atoms, each of R5 and R6 is independently methyl or a hydrogen atom, each of R7 and R8 is methyl, m1 and m2 are 0 or integers of 1 or 2, each of a, b, c and d is independently 0 or 1, and n is 0 or an integer of 1 or 5.

A ZnO-based conductive film having acceptable practical use moisture resistance, properties required for a transparent conductive film, and economical advantage and a method for manufacturing the film are provided. A first ZnO conductive film layer 1, optionally containing a Group III oxide dopant, is formed on a surface of a substrate 11 and a second ZnO conductive film layer 2, which is transparent and includes a Group III oxide different from a Group III oxide (if present) included in the first conductive film layer is formed on the first ZnO conductive film layer to form a multi-layer structure. The thickness of the first ZnO conductive film layer is preferably 5 to 50 nm, and the second and any following ZnO conductive film layers include a Group III oxide at a concentration of 7 wt % or less. The first ZnO conductive film layer is formed under a condition in which high crystallinity can be obtained (for example, under a heat treatment) so as to enhance the crystallinity of the second ZnO conductive film layer and following conductive film layers formed on the first ZnO conductive film layer.

The present invention relates to pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of fenofibrate and the HMG CoA reductase inhibitor pravastatin or a pharmaceutically active salt thereof, which upon oral administration provides a relative AUC0-24 value (AUCfibric acid / AUCpravastatin) of between about 90 and about 6300. The solid compositions are manufactured without any need of addition of water or aqueous medium and comprise at least 80% of the active substances fenofibrate and pravastatin in dissolved form, or, optionally, atorvastatin in micronized form, in order to ensure suitable bioavailability.

A compound has the following formula:The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.

A method for manufacturing an optical cable for communication includes at least one micromodule, said micromodule being blocked with respect to the propagation of water. The method includes the steps of providing at least one optical fiber; embedding the at least one optical fiber in a pseudoplastic filling compound having a viscosity of 3 Pa·s to 30 Pa·s, preferably 7 Pa·s to 25 Pa·s at a shear rate of 10 s−1 and at a temperature of 100° C., and a cross-over lower than 30 Hz, preferably 5 Hz to 25 Hz, at a temperature of 100° C.; and extruding a retaining element made of a thermoplastic polymeric composition around the at least one optical fiber so embedded in the filling compound to obtain a micromodule.

A porous polymer separator layer that exhibits a non-uniform cross-sectional thickness and a method of making the same are disclosed. The porous polymer separator layer may be made by a phase-separation process. This process involves precipitating the porous polymer separator layer from a film having a non-uniform cross-sectional thickness similar to that sought to be imparted to the resultant separator layer. An electrochemical battery cell for a secondary liquid-electrolyte battery may incorporate the disclosed porous polymer separator layer between a negative electrode and a positive electrode in a way that that helps maintain a more evenly distributed current density within the cell.

A ceramic sheet 20 is produced by a method in which inorganic particles including, as a main component, an oxide represented by general formula ABO3 and containing a volatile component are mixed such that the A / B ratio is 1.05 or more, the inorganic particles are formed into a self-supported planar shaped body with a thickness of 30 μm or less, and the shaped body is fired, without an inactive layer or with an inactive layer which does not substantially react with the shaped body and is disposed adjacent to the shaped body, at a temperature-rising rate of 30° C. / min or more in a temperature range which is equal to or higher than a temperature at which the volatile component is volatilized.

The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene oxide (substance with the appropriate plasticity and binding force) and wherein at least the above-mentioned specific size controlling agent is uniformly dispersed in the above-mentioned polyethylene oxide, a controlled-release pharmaceutical composition containing this sized product, and a method of manufacturing a controlled-release pharmaceutical composition containing this sized product.A controlled-release pharmaceutical composition with good uniformity of content can be presented by using powder particles of polyethtylene oxide with powder properties suitable for tableting, which is obtained by uniform dispersion of the specific size controlling agent for polyethylene oxide of the present invention.

The present invention relates to a process for the partial upgrading of properties of heavy and / or extra-heavy crude oil by low severity catalytic hydrotreatment in only one reaction step. The process of the present invention is obtained upgraded oil with properties required for its transportation from offshore platforms either to maritime terminal or to refining centers. The process reduces the viscosity of heavy and / or extra-heavy crude oil, and decreases the concentration of impurities, such as sulfur, nitrogen, and metals, in such a way that heavy and / or extra-heavy crude oils can be transported to maritime terminals or to refining centers. The process increases the lifetime of the catalyst and decreased operating costs by reducing consumption of utilities because the operation of the process is carried out at lower severity. The partially upgraded oils obtained in this process can be transported directly to the maritime terminals or to existing refineries.